U.S. Pharmacist Weekly News Update
April 3, 2019

Older T1D Patients Spend
Too Much Time in
Hypoglycemic State

Pharmacists might caution older type 1 diabetes (T1D) patients that they could be experiencing frequent hypoglycemia without knowing it. Find out how common a recent study found that situation to be.


Amphetamines Cause More Psychosis in ADHD Therapy
Than Methylphenidate

Psychosis is a rare side effect of attention-deficit/hyperactivity disorder (ADHD) treatment. A new study recently determined which medications—amphetamines or methylphenidate—are more likely to cause those symptoms. Here are more details.

Topical Combination Treatment Significantly Reduces Skin
Cancer Risk

Squamous cell carcinoma is among the most common types of skin cancer. So a new study finding that a topical treatment dramatically reduces the risk of the condition is especially significant. Find out what other benefits are linked to a topical chemotherapy and an immune-system-activating compound.

Immunosuppressive Combinations Safe for Older Crohn’s Patients
Even though a significant percentage of Crohn’s disease patients are older than age 60 years, some of the most effective medications haven’t been used in that age group because of safety concerns. Now, a new study finds that older adults can be safely and effectively treated with combined immunosuppression. Here is more information.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App